Stock Analysts’ Ratings Reiterations for November 6th (ABNB, ACLS, AFRM, ALB, ARLO, ATO, AUTO, AXON, BETA, BTA)

Stock Analysts’ ratings reiterations for Friday, November 6th:

Airbnb (NASDAQ:ABNB) had its neutral rating reaffirmed by analysts at Piper Sandler. They currently have a $180.00 target price on the stock, up from their previous target price of $170.00.

Airbnb (NASDAQ:ABNB) had its buy rating reissued by analysts at B. Riley Financial. B. Riley Financial currently has a $230.00 target price on the stock, up from their previous target price of $210.00.

Axcelis Technologies (NASDAQ:ACLS) had its buy rating reiterated by analysts at B. Riley Financial. The firm currently has a $140.00 target price on the stock, down from their previous target price of $165.00.

Affirm (NASDAQ:AFRM) had its market outperform rating reaffirmed by analysts at Citizens Jmp. The firm currently has a $85.00 target price on the stock.

Albemarle (NYSE:ALB) had its buy rating reissued by analysts at Truist Financial. Truist Financial currently has a $170.00 price target on the stock, down from their previous price target of $185.00.

Arlo Technologies (NYSE:ARLO) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $17.00 price target on the stock, up from their previous price target of $16.00.

Atmos Energy (NYSE:ATO) had its overweight rating reissued by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $201.00 target price on the stock.

Auto Trader Group (LON:AUTO) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 794 target price on the stock.

Axon Enterprise (NASDAQ:AXON) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $540.00 price target on the stock, down from their previous price target of $561.00.

BETA Technologies (NYSE:BETA) had its buy rating reiterated by analysts at BTIG Research. They currently have a $33.00 price target on the stock.

BlackRock Long-Term Municipal Advantage Trust’s (LON:BTA) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 150 target price on the stock.

Celsius (NASDAQ:CELH) had its buy rating reaffirmed by analysts at B. Riley Financial. B. Riley Financial currently has a $53.00 price target on the stock, down from their previous price target of $56.00.

Cigna Group (NYSE:CI) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $340.00 price target on the stock.

Croda International (LON:CRDA) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 3,300 price target on the stock.

Conduit (LON:CRE) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 765 price target on the stock.

Comstock Resources (NYSE:CRK) had its hold rating reiterated by analysts at Truist Financial. The firm currently has a $15.00 price target on the stock, down from their previous price target of $16.00.

Diageo (LON:DGE) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 2,223 target price on the stock.

Doximity (NYSE:DOCS) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $41.00 target price on the stock.

Enliven Therapeutics (NASDAQ:ELVN) had its buy rating reiterated by analysts at Guggenheim. They currently have a $78.00 target price on the stock.

Shift4 Payments (NYSE:FOUR) had its buy rating reissued by analysts at B. Riley Financial. The firm currently has a $77.00 target price on the stock, down from their previous target price of $94.00.

Molten Ventures (LON:GROW) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 877 target price on the stock.

Honest (NASDAQ:HNST) had its buy rating reaffirmed by analysts at B. Riley Financial. The firm currently has a $5.50 price target on the stock, up from their previous price target of $5.00.

Hut 8 (NASDAQ:HUT) had its buy rating reissued by analysts at B. Riley Financial. They currently have a $132.00 price target on the stock, down from their previous price target of $134.00.

Howden Joinery Group (LON:HWDN) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 1,210 target price on the stock.

Karman (NYSE:KRMN) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $60.00 price target on the stock, up from their previous price target of $59.00.

Malibu Boats (NASDAQ:MBUU) had its neutral rating reissued by analysts at B. Riley Financial. They currently have a $22.00 price target on the stock, down from their previous price target of $30.00.

Morgan Sindall Group (LON:MGNS) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 6,200 target price on the stock.

Magnolia Oil & Gas (NYSE:MGY) had its buy rating reiterated by analysts at Truist Financial. The firm currently has a $37.00 target price on the stock, up from their previous target price of $35.00.

Cloudflare (NYSE:NET) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $337.00 target price on the stock, up from their previous target price of $333.00.

Next 15 Group (LON:NFG) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 473 price target on the stock.

Novavax (NASDAQ:NVAX) had its buy rating reiterated by analysts at B. Riley Financial. B. Riley Financial currently has a $16.00 target price on the stock, down from their previous target price of $18.00.

BeOne Medicines (NASDAQ:ONC) had its buy rating reiterated by analysts at Truist Financial. Truist Financial currently has a $448.00 target price on the stock, up from their previous target price of $420.00.

Ormat Technologies (NYSE:ORA) had its market perform rating reiterated by analysts at Sanford C. Bernstein. The firm currently has a $112.00 price target on the stock.

Solventum (NYSE:SOLV) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $110.00 target price on the stock, up from their previous target price of $105.00.

Oncology Institute (NASDAQ:STLN) had its buy rating reaffirmed by analysts at B. Riley Financial. They currently have a $10.00 price target on the stock, down from their previous price target of $11.00.

Atlassian (NASDAQ:TEAM) had its buy rating reaffirmed by analysts at Truist Financial. Truist Financial currently has a $200.00 price target on the stock, down from their previous price target of $250.00.

Trinity Capital (NASDAQ:TRIN) had its buy rating reaffirmed by analysts at B. Riley Financial. B. Riley Financial currently has a $20.00 target price on the stock, up from their previous target price of $19.00.

Trainline (LON:TRN) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 350 target price on the stock.

Sixth Street Specialty Lending (NYSE:TSLX) had its buy rating reissued by analysts at B. Riley Financial. They currently have a $19.00 price target on the stock, down from their previous price target of $20.00.

Unity Software (NYSE:U) had its outperform rating reiterated by analysts at Oppenheimer. They currently have a $64.00 price target on the stock, up from their previous price target of $47.00.

US Foods (NYSE:USFD) had its buy rating reiterated by analysts at BTIG Research. They currently have a $120.00 price target on the stock.

Advanced Drainage Systems (NYSE:WMS) had its outperform rating reiterated by analysts at Oppenheimer. They currently have a $180.00 price target on the stock, down from their previous price target of $185.00.

Xeris Biopharma (NASDAQ:XERS) had its outperform rating reissued by analysts at Oppenheimer. The firm currently has a $21.00 target price on the stock, up from their previous target price of $18.00.

Xeris Biopharma (NASDAQ:XERS) had its neutral rating reissued by analysts at Piper Sandler. They currently have a $12.00 price target on the stock, up from their previous price target of $8.00.